Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Pharnext, SAS
ClinicalTrials.gov Identifier:
NCT01401257
First received: July 20, 2011
Last updated: September 11, 2013
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)